Fate Therapeutics recently announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for the lupus treatment candidate FT819.

In a new letter, published in the Journal of the European Academy of Dermatology and Venereology, members of the lupus ...

A new study explores the relationship between frailty, the proportion of health deficits present in an individual, as ...

A new study published in The Journal of the American Heart Association provides insights to improve cardiovascular disease ...

Health insurance is important for everyone. But for people with lupus — or anyone who needs more frequent medical care — it’s especially important to have health insurance to help lower your overall ...

In a new letter, published in the Journal of the European Academy of Dermatology and Venereology, members of the lupus community underscore the critical need to recognize the unique challenges of ...

Managing lupus can come with significant health care costs that can have a big impact on a person’s or family’s overall finances. And costs can be especially high during the diagnosis process. While ...